Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D006816:Huntington Disease / Q000097:blood / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D007538:Isoniazid / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D005680:gamma-Aminobutyric Acid / Q000097:blood / Q000134:cerebrospinal fluid*
D010919:Placebos; D005680:gamma-Aminobutyric Acid; D007538:Isoniazid